Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model

References

• Scheltens P, Blennow K, Breteler MM, et al. Alzheimer‘s disease. Lancet. 2016 Jul 30;388(10043):505–517. PubMed PMID: 26921134.
   PubMed Web of Science ®Google Scholar
• Wang J, Gu BJ, Masters CL, et al. A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol. 2017 Sep 29;13(10):612–623. PubMed PMID: 28960209.
   PubMed Web of Science ®Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer‘s disease. N Engl J Med. 2010 Jan 28;362(4):329–344. PubMed PMID: 20107219.
   PubMed Web of Science ®Google Scholar
• Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-amyloid in Alzheimer‘s disease. Science. 2010 Dec 24;330(6012):1774. PubMed PMID: 21148344; PubMed Central PMCID: PMC3073454.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer‘s disease at 25 years. EMBO Mol Med. 2016 Jun;8(6):595–608. PubMed PMID: 27025652; PubMed Central PMCID: PMC4888851.
   PubMed Web of Science ®Google Scholar
• Sevigny J, Chiao P, Bussière T, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. 2016 Sep 1;537(7618):50–56. PubMed PMID: 27582220.
   PubMed Web of Science ®Google Scholar
• Bu XL, Xiang Y, Jin WS, et al. Blood-derived amyloid-beta protein induces Alzheimer‘s disease pathologies. Mol Psychiatry. 2017 Oct 31. PubMed PMID: 29086767. DOI:10.1038/mp.2017.204
   Web of Science ®Google Scholar
• Jin WS, Shen LL, Bu XL, et al. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model. Acta Neuropathol. 2017 Aug;134(2):207–220. PubMed PMID: 28477083.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015 Jun;16(6):345–357. PubMed PMID: 25991442.
   PubMed Web of Science ®Google Scholar
• Chung KM, Hernandez N, Sproul AA, et al. Alzheimer‘s disease and the autophagic-lysosomal system. Neurosci Lett. 2018 May 18. pii: S0304-3940(18):30344-6. PubMed PMID: 29758300. DOI:10.1016/j.neulet.2018.05.017
   Web of Science ®Google Scholar
• Metaxakis A, Ploumi C, Tavernarakis N. Autophagy in age-associated neurodegeneration. Cells. 2018 May 5;7(5):pii: E37. PubMed PMID: 29734735; PubMed Central PMCID: PMC5981261.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Majumder S, Richardson A, et al. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010 Apr 23;285(17):13107–13120. PubMed PMID: 20178983; PubMed Central PMCID: PMC2857107.
   PubMed Web of Science ®Google Scholar
• Pickford F, Masliah E, Britschgi M, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 2008 Jun;118(6):2190–2199. PubMed PMID: 18497889; PubMed Central PMCID: PMC2391284.
   PubMed Web of Science ®Google Scholar
• Swaminathan G, Zhu W, Plowey ED. BECN1/Beclin 1 sorts cell-surface APP/amyloid β precursor protein for lysosomal degradation. Autophagy. 2016 Dec;12(12):2404–2419. PubMed PMID: 27715386; PubMed Central PMCID: PMC5173276.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Yan P, Ma X, et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing Abeta generation and amyloid plaque pathogenesis. J Neurosci. 2015 Sep 2;35(35):12137–12151. PubMed PMID: 26338325; PubMed Central PMCID: PMC4556784.
   PubMed Web of Science ®Google Scholar
• Zhang YD, Zhao JJ. TFEB participates in the Aβ-induced pathogenesis of Alzheimer‘s disease by regulating the autophagy-lysosome pathway. DNA Cell Biol. 2015 Nov;34(11):661–668. PubMed PMID: 26368054.
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006 Jun 15;441(7095):885–889. PubMed PMID: 16625204.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006 Jun 15;441(7095):880–884. PubMed PMID: 16625205.
   PubMed Web of Science ®Google Scholar
• Yang DS, Stavrides P, Mohan PS, et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer‘s disease ameliorates amyloid pathologies and memory deficits. Brain. 2011 Jan;134(Pt 1):258–277. PubMed PMID: 21186265; PubMed Central PMCID: PMC3009842.
   PubMed Web of Science ®Google Scholar
• Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol. 2011 Dec 20;8(2):108–117. PubMed PMID: 22187000.
   PubMed Web of Science ®Google Scholar
• Schaeffer V, Goedert M. Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy. 2012 Nov;8(11):1686–1687. PubMed PMID: 22874558; PubMed Central PMCID: PMC3494601.
   PubMed Web of Science ®Google Scholar
• Di Meco A, Li JG, Blass BE, et al. 12/15-Lipoxygenase inhibition reverses cognitive impairment, brain amyloidosis, and tau pathology by stimulating autophagy in aged triple transgenic mice. Biol Psychiatry. 2017 Jan 15;81(2):92–100. PubMed PMID: 27499089.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Ferreira E, Branca C, et al. p62 improves AD-like pathology by increasing autophagy. Mol Psychiatry. 2017 Jun;22(6):865–873. PubMed PMID: 27573878; PubMed Central PMCID: PMC5479312.
   PubMed Web of Science ®Google Scholar
• Frake RA, Ricketts T, Menzies FM, et al. Autophagy and neurodegeneration. J Clin Invest. 2015 Jan;125(1):65–74. PubMed PMID: 25654552; PubMed Central PMCID: PMC4382230.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Ahmed Z, Bradfute SB, et al. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential. Nat Commun. 2015 Oct 27;6:8620. PubMed PMID: 26503418; PubMed Central PMCID: PMC4624223.
   PubMed Web of Science ®Google Scholar
• Keller H, Dreyer C, Medin J, et al. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2160–2164. PubMed PMID: 8384714; PubMed Central PMCID: PMC46045.
   PubMed Web of Science ®Google Scholar
• Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature. 1998 Jun 25;393(6687):790–793. PubMed PMID: 9655393; PubMed Central PMCID: PMC 9655393.
   PubMed Web of Science ®Google Scholar
• Kersten S. Integrated physiology and systems biology of PPARalpha. Mol Metab. 2014 Jul;3(4):354–371. PubMed PMID: 24944896; PubMed Central PMCID: PMC4060217.
   PubMed Web of Science ®Google Scholar
• Mandard S, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci. 2004 Feb;61(4):393–416. PubMed PMID: 14999402.
   PubMed Web of Science ®Google Scholar
• Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet. 1999 Jul 10;354(9173):141–148. PubMed PMID: 10408502.
   PubMed Web of Science ®Google Scholar
• Lee JM, Wagner M, Xiao R, et al. Nutrient-sensing nuclear receptors coordinate autophagy. Nature. 2014 Dec 4;516(7529):112–115. PubMed PMID: 25383539; PubMed Central PMCID: PMC4267857.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee HM, Kim JK, et al. PPAR-alpha activation mediates innate host defense through induction of TFEB and lipid catabolism. J Immunol. 2017 Apr 15;198(8):3283–3295. PubMed PMID: 28275133.
   PubMed Web of Science ®Google Scholar
• Kolsch H, Lehmann DJ, Ibrahim-Verbaas CA, et al. Interaction of insulin and PPAR-alpha genes in Alzheimer‘s disease: the Epistasis Project. J Neural Transm (Vienna). 2012 Apr;119(4):473–479. PubMed PMID: 22065208.
   PubMed Web of Science ®Google Scholar
• Corbett GT, Gonzalez FJ, Pahan K. Activation of peroxisome proliferator-activated receptor alpha stimulates ADAM10-mediated proteolysis of APP. Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8445–8450. PubMed PMID: 26080426; PubMed Central PMCID: PMC4500265.
   PubMed Web of Science ®Google Scholar
• Roy A, Jana M, Kundu M, et al. HMG-CoA reductase inhibitors bind to PPARalpha to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab. 2015 Aug 4;22(2):253–265. PubMed PMID: 26118928; PubMed Central PMCID: PMC4526399.
   PubMed Web of Science ®Google Scholar
• Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density lipoprotein cholesterol intervention trial Study group. N Engl J Med. 1999 Aug 5;341(6):410–418. PubMed PMID: 10438259; PubMed Central PMCID: PMC10438259.
   PubMed Web of Science ®Google Scholar
• Frick MH, Elo O, Haapa K, et al. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. PubMed PMID: 3313041; PubMed Central PMCID: PMC3313041.
   PubMed Web of Science ®Google Scholar
• Zhang DF, Li J, Wu H, et al. CFH variants affect structural and functional brain changes and genetic risk of Alzheimer’s disease. Neuropsychopharmacol. 2016 Mar;41(4):1034–1045. PubMed PMID: 26243271; PubMed Central PMCID: PMC4748428.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Cuervo AM, Ravikumar B, et al. In search of an “autophagomometer”. Autophagy. 2009 Jul;5(5):585–589. PubMed PMID: 19411822.
   PubMed Web of Science ®Google Scholar
• Feng L, Ma Y, Sun J, et al. YY1-MIR372-SQSTM1 regulatory axis in autophagy. Autophagy. 2014 Aug;10(8):1442–1453. PubMed PMID: 24991827; PubMed Central PMCID: PMC4203520.
   PubMed Web of Science ®Google Scholar
• Jankowsky JL, Fadale DJ, Anderson J, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004 Jan 15;13(2):159–170. PubMed PMID: 14645205.
   PubMed Web of Science ®Google Scholar
• Giannopoulos PF, Chu J, Joshi YB, et al. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer‘s disease. Mol Psychiatry. 2014 Apr;19(4):511–518. PubMed PMID: 23478745; PubMed Central PMCID: PMC3688674.
   PubMed Web of Science ®Google Scholar
• Giannopoulos PF, Chu J, Sperow M, et al. Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy. Biol Psychiatry. 2015 Nov 15;78(10):693–701. PubMed PMID: 25802082; PubMed Central PMCID: PMC4529386.
   PubMed Web of Science ®Google Scholar
• Di Meco A, Joshi YB, Lauretti E, et al. Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice. Mol Psychiatry. 2016 Mar;21(3):403–410. PubMed PMID: 26077691.
   PubMed Web of Science ®Google Scholar
• Pietrzak RH, Lim YY, Neumeister A, et al. Amyloid-beta, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. JAMA Psychiatry. 2015 Mar;72(3):284–291. PubMed PMID: 25629787.
   PubMed Web of Science ®Google Scholar
• Seibenhener ML, Wooten MC. Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015 Feb 6;(96):e52434. PubMed PMID: 25742564; PubMed Central PMCID: PMC4354627. DOI:10.3791/52434
   PubMed Web of Science ®Google Scholar
• Attwood BK, Bourgognon JM, Patel S, et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature. 2011 May 19;473(7347):372–375. PubMed PMID: 21508957; PubMed Central PMCID: PMC3145099.
   PubMed Web of Science ®Google Scholar
• Mucke L, Selkoe DJ. Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. CSH Perspect Med. 2012 Jul;2(7):a006338–a006338. PubMed PMID: 22762015; PubMed Central PMCID: PMC3385944
   Google Scholar
• Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014 Jan;112:24–49. PubMed PMID: 24211851.
   PubMed Web of Science ®Google Scholar
• Shao Y, Gearing M, Mirra SS. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study. J Neuropathol Exp Neurol. 1997 Apr;56(4):376–381. PubMed PMID: 9100668.
   PubMed Web of Science ®Google Scholar
• Pihlaja R, Koistinaho J, Malm T, et al. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer‘s disease. Glia. 2008 Jan 15;56(2):154–163. PubMed PMID: 18004725.
   PubMed Web of Science ®Google Scholar
• Nicoll JA, Weller RO. A new role for astrocytes: β-amyloid homeostasis and degradation. Trends Mol Med. 2003 Jul;9(7):281–282. PubMed PMID: 12900213.
   PubMed Web of Science ®Google Scholar
• McGeer PL, Itagaki S, Tago H, et al. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett. 1987 Aug 18;79(1–2):195–200. PubMed PMID: 3670729.
   PubMed Web of Science ®Google Scholar
• Simard AR, Soulet D, Gowing G, et al. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer‘s disease. Neuron. 2006 Feb 16;49(4):489–502. PubMed PMID: 16476660.
   PubMed Web of Science ®Google Scholar
• Gomez-Nicola D, Perry VH. Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. Neuroscientist. 2015 Apr;21(2):169–184. PubMed PMID: 24722525; PubMed Central PMCID: PMC4412879.
   PubMed Web of Science ®Google Scholar
• Malm TM, Jay TR, Landreth GE. The evolving biology of microglia in Alzheimer‘s disease. Neurotherapeutics. 2014 Jan;12(1):81–93. PubMed PMID: 25404051; PubMed Central PMCID: PMC4322081.
   Web of Science ®Google Scholar
• Liu Z, Condello C, Schain A, et al. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J Neurosci. 2010 Dec 15;30(50):17091–17101. PubMed PMID: 21159979; PubMed Central PMCID: PMC3077120.
   PubMed Web of Science ®Google Scholar
• Lee S, Varvel NH, Konerth ME, et al. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer‘s disease mouse models. Am J Pathol. 2010 Nov;177(5):2549–2562. PubMed PMID: 20864679; PubMed Central PMCID: PMC2966811.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer‘s disease. Nat Immunol. 2015 Mar;16(3):229–236. PubMed PMID: 25689443.
   PubMed Web of Science ®Google Scholar
• Alves S, Churlaud G, Audrain M, et al. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer‘s disease mice. Brain. 2017 Mar 1;140(3):826–842. PubMed PMID: 28003243.
   PubMedGoogle Scholar
• Zotova E, Bharambe V, Cheaveau M, et al. Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization. Brain. 2013 Sep;136(9):2677–2696. PubMed PMID: 23943781.
   PubMedGoogle Scholar
• Guillot-Sestier MV, Doty KR, Gate D, et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron. 2015 Feb 4;85(3):534–548. PubMed PMID: 25619654; PubMed Central PMCID: PMC4352138.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cella M, Mallinson K, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer‘s disease model. Cell. 2015 Mar 12;160(6):1061–1071. PubMed PMID: 25728668; PubMed Central PMCID: PMC4477963.
   PubMed Web of Science ®Google Scholar
• de la Monte SM, Wands JR. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer‘s disease. J Alzheimers Dis. 2006 Jul;9(2):167–181. PubMed PMID: 16873964.
   PubMed Web of Science ®Google Scholar
• Combs CK, Bates P, Karlo JC, et al. Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem Int. 2001 Nov-Dec;39(5–6):449–457. PubMed PMID: 11578780.
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Carvajal FJ, Zolezzi JM, et al. Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer‘s disease. J Alzheimers Dis. 2013;33(4):941–959. PubMed PMID: 23109558.
   PubMed Web of Science ®Google Scholar
• Lalonde R, Kim HD, Fukuchi K. Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 mice. Neurosci Lett. 2004 Oct 14;369(2):156–161. PubMed PMID: 15450687.
   PubMed Web of Science ®Google Scholar
• Lalonde R, Kim HD, Maxwell JA, et al. Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett. 2005 Dec 23;390(2):87–92. PubMed PMID: 16169151.
   PubMed Web of Science ®Google Scholar
• Reiserer RS, Harrison FE, Syverud DC, et al. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer‘s disease. Genes Brain Behav. 2007 Feb;6(1):54–65. PubMed PMID: 17233641.
   PubMed Web of Science ®Google Scholar
• Pugh PL, Richardson JC, Bate ST, et al. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer‘s disease. Behav Brain Res. 2007 Mar 12;178(1):18–28. PubMed PMID: 17229472.
   PubMed Web of Science ®Google Scholar
• Olesen LØ, Bouzinova EV, Severino M, et al. Behavioural phenotyping of APPswe/PS1δE9 mice: age-rrelated changes and effect of long-term paroxetine treatment. PLoS One. 2016 Nov 4;11(11):e0165144. PubMed PMID: 27814403; PubMed Central PMCID: PMC5096719.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yoo MJ, Savonenko A, et al. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer‘s disease. J Neurosci. 2008 Dec 17;28(51):13805–13814. PubMed PMID: 19091971.
   PubMed Web of Science ®Google Scholar
• Gao JY, Chen Y, Su DY, et al. Anxiety-like but not despair-like behaviors are further aggravated by chronic mild stress in the early stages of APPswe/PS1dE9 transgenic mice. BioRxiv. 2017 Oct 12. DOI:10.1101/202283
   Google Scholar
• Yu WH, Cuervo AM, Kumar A, et al. Macroautophagy–a novel Beta-amyloid peptide-generating pathway activated in Alzheimer‘s disease. J Cell Biol. 2005 Oct 10;171(1):87–98. PubMed PMID: 16203860; PubMed Central PMCID: PMC2171227.
   PubMed Web of Science ®Google Scholar
• Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007 Dec 1;120(Pt 23):4081–4091. PubMed PMID: 18032783.
   PubMed Web of Science ®Google Scholar
• Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013 Aug;19(8):983–997. PubMed PMID: 23921753.
   PubMed Web of Science ®Google Scholar
• Lucin KM, O‘Brien CE, Bieri G, et al. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer‘s disease. Neuron. 2013 Sep 4;79(5):873–886. PubMed PMID: 24012002; PubMed Central PMCID: PMC3779465.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Jana M, Modi K, et al. Activation of peroxisome proliferator-activated receptor alpha induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders. J Biol Chem. 2015 Apr 17;290(16):10309–10324. PubMed PMID: 25750174; PubMed Central PMCID: PMC4400343.
   PubMed Web of Science ®Google Scholar
• Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA. 2001 Mar 28;285(12):1585–1591. PubMed PMID: 11268266.
   PubMed Web of Science ®Google Scholar
• Koistinaho M, Lin S, Wu X, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004 Jul;10(7):719–726. PubMed PMID: 15195085.
   PubMed Web of Science ®Google Scholar
• Meyer-Luehmann M, Prinz M. Myeloid cells in Alzheimer‘s disease: culprits, victims or innocent bystanders? Trends Neurosci. 2015 Oct;38(10):659–668. PubMed PMID: 26442698.
   PubMed Web of Science ®Google Scholar
• Lee CYD, Landreth GE. The role of microglia in amyloid clearance from the AD brain. J Neural Transm. 2010 Aug;117(8):949–960. PubMed PMID: 20552234; PubMed Central PMCID: PMCPMC3653296.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005 May 27;308(5726):1314–1318. PubMed PMID: 15831717.
   PubMed Web of Science ®Google Scholar
• Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009 Oct 15;64(1):110–122. PubMed PMID: 19840553; PubMed Central PMCID: PMC2834890.
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011 Sep 9;333(6048):1456–1458. PubMed PMID: 21778362.
   PubMed Web of Science ®Google Scholar
• Herber DL, Roth LM, Wilson D, et al. Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice. Exp Neurol. 2004 Nov;190(1):245–253. PubMed PMID: 15473997.
   PubMed Web of Science ®Google Scholar
• Herber DL, Mercer M, Roth LM, et al. Microglial activation is required for Aβ clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharm. 2007 Jun;2(2):222–231. PubMed PMID: 18040847.
   PubMed Web of Science ®Google Scholar
• DiCarlo G, Wilcock D, Henderson D, et al. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol Aging. 2001 Nov-Dec;22(6):1007–1012. PubMed PMID: 11755009.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer‘s disease. Lancet Neurol. 2015 Apr;14(4):388–405. PubMed PMID: 25792098; PubMed Central PMCID: PMC5909703.
   PubMed Web of Science ®Google Scholar
• Abeti R, Abramov AY, Duchen MR. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain. 2011 Jun;134(Pt 6):1658–1672. PubMed PMID: 21616968.
   PubMedGoogle Scholar
• Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer‘s disease mice. J Neurosci. 2008 Aug 13;28(33):8354–8360. PubMed PMID: 18701698; PubMed Central PMCID: PMC2597474.
   PubMed Web of Science ®Google Scholar
• El Khoury J, Toft M, Hickman SE, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med. 2007 Apr;13(4):432–438. PubMed PMID: 17351623.
   PubMed Web of Science ®Google Scholar
• Kaifu T, Nakahara J, Inui M, et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest. 2003 Feb;111(3):323–332. PubMed PMID: 12569157; PubMed Central PMCID: PMC151867.
   PubMed Web of Science ®Google Scholar
• Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 2001 Jul 13;293(5528):306–311. PubMed PMID: 11452127.
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T, Yan F, Lin AHT, et al. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer‘s mice. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10837–10842. PubMed PMID: 12119423; PubMed Central PMCID: PMC125059.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Kummer MP, Stutz A, et al. NLRP3 is activated in Alzheimer‘s disease and contributes to pathology in APP/PS1 mice. Nature. 2013 Jan 31;493(7434):674–678. PubMed PMID: 23254930; PubMed Central PMCID: PMC3812809.
   PubMed Web of Science ®Google Scholar
• Su LY, Luo R, Liu Q, et al. Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine. Autophagy. 2017 Jul 19;13(9):1496–1511. PubMed PMID: 28722508; PubMed Central PMCID: PMC5612517.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222. PubMed PMID: 26799652; PubMed Central PMCID: PMC4835977.
   PubMed Web of Science ®Google Scholar
• Burgess A, Vigneron S, Brioudes E, et al. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12564–12569. PubMed PMID: 20538976; PubMed Central PMCID: PMC2906566.
   PubMed Web of Science ®Google Scholar
• Krauthausen M, Kummer MP, Zimmermann J, et al. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer‘s disease model. J Clin Invest. 2015 Jan;125(1):365–378. PubMed PMID: 25500888; PubMed Central PMCID: PMC4382235.
   PubMed Web of Science ®Google Scholar